These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15761222)

  • 1. Initial safety experience of abciximab and heparin for acute ischemic stroke.
    Mandava P; Lick SD; Rahman MA; Langsjoen H; Reddy KV; Nelson J; Kent TA
    Cerebrovasc Dis; 2005; 19(4):276-8. PubMed ID: 15761222
    [No Abstract]   [Full Text] [Related]  

  • 2. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window.
    Mitsias PD; Lu M; Silver B; Morris D; Ewing JR; Daley S; Lewandowski C; Katramados A; Papamitsakis NI; Ebadian HB; Zhao Q; Soltanian-Zadeh H; Hearshen D; Patel SC; Chopp M
    Neurology; 2005 Aug; 65(4):612-5. PubMed ID: 16116128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
    Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
    Lenderink T; Boersma E; Ruzyllo W; Widimsky P; Ohman EM; Armstrong PW; Wallentin L; Simoons ML;
    Am Heart J; 2004 May; 147(5):865-73. PubMed ID: 15131544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue treatment with abciximab in acute ischemic stroke.
    Lee KY; Heo JH; Lee SI; Yoon PH
    Neurology; 2001 Jun; 56(11):1585-7. PubMed ID: 11402123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
    Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H
    Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials.
    Blankenship JC; Balog C; Sapp SK; Califf RM; Lincoff AM; Tcheng JE; Topol EJ
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):476-83. PubMed ID: 12455081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window.
    Mandava P; Anderson JA; Kent TA
    Neurology; 2006 Apr; 66(7):1132. PubMed ID: 16606946
    [No Abstract]   [Full Text] [Related]  

  • 10. Right atrial thrombus treated successfully with abciximab and heparin.
    Borges AC; Reibis RK; Claus M; Baumann G
    J Thromb Thrombolysis; 2001 Dec; 12(3):283-7. PubMed ID: 11981111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results.
    Capuano C; Sesana M; Leonzi O; Cuccia C
    J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ; Turner N; Clague JR; Oldershaw PJ; Burman JF
    Thromb Haemost; 1999 Nov; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe intracranial hemorrhage after emergency carotid stenting and abciximab administration for postoperative thrombosis.
    Moshiri S; Di Mario C; Liistro F; Melissano G; Chiesa R; Colombo A
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):225-8. PubMed ID: 11387609
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of periprocedural heparin in acute ischemic stroke endovascular therapy: the multi MERCI trial.
    Nahab F; Walker GA; Dion JE; Smith WS
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):790-3. PubMed ID: 21640610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
    Kereiakes DJ; Fry E; Matthai W; Niederman A; Barr L; Brodie B; Zidar J; Casale P; Christy G; Moliterno D; Lengerich R; Broderick T; Shimshak T; Cohen M
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():1A-5A. PubMed ID: 10731289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic Pericarditis Leading to Cardiac Tamponade Following Abciximab Therapy.
    Inayat F; Mirza F; Sultan Rai AB
    J Coll Physicians Surg Pak; 2016 May; 26(5):447-8. PubMed ID: 27225159
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary hemorrhage and acute pulmonary thromboembolism after abciximab administration.
    Conrotto F; Scacciatella P; Usmiani T; Grasso C; Ebrille E; D'Amico M; Marra S
    Am J Emerg Med; 2013 Feb; 31(2):450.e1-2. PubMed ID: 22980359
    [No Abstract]   [Full Text] [Related]  

  • 19. Incomplete resolution of basilar artery occlusion after intra-arterial thrombolysis: abciximab and heparin prevent early rethrombosis.
    Küker W; Friese S; Vogel W; Schmidt F; Weller M
    Cerebrovasc Dis; 2000; 10(6):484-6. PubMed ID: 11070384
    [No Abstract]   [Full Text] [Related]  

  • 20. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
    Kereiakes DJ; Grines C; Fry E; Esente P; Hoppensteadt D; Midei M; Barr L; Matthai W; Todd M; Broderick T; Rubinstein R; Fareed J; Santoian E; Neiderman A; Brodie B; Zidar J; Ferguson JJ; Cohen M;
    J Invasive Cardiol; 2001 Apr; 13(4):272-8. PubMed ID: 11287711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.